Immutep Ltd Files Routine 6-K Disclosure
Ticker: PRRUF · Form: 6-K · Filed: Jun 4, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, disclosure
TL;DR
IMMUTEP files routine 6-K, no new info, just compliance.
AI Summary
Immutep Limited filed a Form 6-K on June 4, 2024, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is incorporated in Australia and has its principal executive offices in Sydney. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating ongoing compliance with SEC reporting requirements without providing new material information.
Risk Assessment
Risk Level: low — This filing is a routine procedural disclosure and does not contain new material information that would impact the company's risk profile.
Key Players & Entities
- IMMUTEP Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- Sydney NSW 2000, Australia (location) — Principal executive office location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the registrant makes or is required to make public pursuant to the laws of its home country.
When was this Form 6-K filed?
This Form 6-K was filed on June 4, 2024.
What was Immutep Limited's former name?
Immutep Limited was formerly known as Prima BioMed Ltd.
Where are Immutep Limited's principal executive offices located?
Immutep Limited's principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Does this filing indicate Immutep Limited is submitting its annual report on Form 20-F?
Yes, the filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
Filing Stats: 266 words · 1 min read · ~1 pages · Grade level 17.6 · Accepted 2024-06-04 07:35:55
Filing Documents
- d641939d6k.htm (6-K) — 9KB
- d641939dex991.htm (EX-99.1) — 18KB
- g641939dsp4.jpg (GRAPHIC) — 18KB
- 0001193125-24-153648.txt ( ) — 53KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: June 03, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer